Varicella zoster virus (VZV) is a species specific herpesvirus which infects sensory
Varicella zoster virus (VZV) is the aetiological agent for varicella (chicken pox) and herpes zoster (shingles) (1, 3) . During primary varicella infection, VZV accesses nerve axons to reach sensory ganglia, where it establishes latency (4, 5, 7, 15, 16) .
Reactivation from latency results in new infectious virus and axonal transport of VZV to the skin to cause herpes zoster. During herpes zoster neural and dermoepidermal inflammation occurs, resulting in neuropathic pain and the typical dermatomal rash (8) . The complex aberrant repair processes that occur during herpes zoster can result in chronic neuropathic pain (post herpetic neuralgia; PHN), which can last for years after resolution of the rash (26).
The high species specificity of VZV has complicated the development of small animal models that mimic productive infection (1, 17) , although advances in tissue culture techniques enabled the development of SCID-hu mouse models utilizing grafted human tissue (17, 18, 20, 21) . Grafting of neural cells has been used to examine infection of neurons and glial cells (2) . In a variation of this model, intact human fetal DRG have been grafted into SCID-hu mice to show that after initial productive infection, VZV persisted in a form consistent with the establishment of latency (29).
We have previously shown that single cell preparations of neurons from dissociated human DRG support virus replication and that unlike productive infection of human fibroblasts (HFs), infected neurons are resistant to apoptosis (13) . We also provided evidence that the VZV ORF 63 gene product confers resistance to apoptosis during neuronal infection (12) . In an extension of these studies, we sought to develop a human explant ganglia model as a means to study features of VZV interactions with ganglionic cells within the context of the intact ganglia. Ethics Committee. Individual intact DRG were isolated from fetal spinal tissue and cultured on glass coverslips as previously described (24). Axons typically developed at day 2 post explant and only DRG with extensive axonal growth were used for infection ( Figure 1A ). Due to the highly cell associated nature of VZV in vitro (27), a cell associated inoculation method was utilised. Single DRG explants each cultured in 700 µl of neuronal culture media (DMEM with 0.5% fetal calf serum, 100ng/ml nerve growth factor, 100 U/ml penicllin/streptomycin, 2mM L-glutamine, B-27 Supplements, GIBCO, CA) were incubated with an inoculum consisting of 100 µl of antigens were unmasked using 0.01M citrate buffer pH 6 prior to incubation with primary antibodies to the neural cell adhesion molecule (NCAM; monoclonal mouse anti-human antibody, Chemicon Inc, CA) or to S100 proteins, which are expressed on satellite cells and some neurons (2, 9) . The antibody used to detect S100 was a rabbit anti-cow S100 polyclonal antibody (Dako). As described by the manufacturer, this antibody reacts strongly with human S100B, weakly with S100A1, very weakly with S100A6 and does not react with other S100 proteins such as S100A2, A3 and A4.
A C C E P T E D

Bound antibodies were detected using HRP and DAB. NCAM-positive neurons were readily detected, as were surrounding smaller satellite cells expressing S100 ( Figure   1D , E). In both mock-and VZV infected ganglia, the number of S100-expressing cells increased over time post explant, consistent with studies of mouse and rat sensory ganglia reporting that the process of explanting ganglia can induce satellite cell proliferation (6, 28).
VZV glycoproteins are not expressed at detectable levels during latency and so their detection is a useful indicator of productive infection (10 
